IGMS
IGM Biosciences
IGMS
IGMS
Delisted
IGMS was delisted on the 13th of August, 2025.
109 hedge funds and large institutions have $1.38B invested in IGM Biosciences in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 40 increasing their positions, 34 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
9% less capital invested
Capital invested by funds: $1.52B → $1.38B (-$135M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
74% less call options, than puts
Call options by funds: $7.08M | Put options by funds: $27.5M
Holders
109
Holding in Top 10
1
Calls
$7.08M
Puts
$27.5M
Top Buyers
| 1 | +$41M | |
| 2 | +$35.9M | |
| 3 | +$16.3M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$10.9M |
| 5 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$9.59M |
Top Sellers
| 1 | -$17.9M | |
| 2 | -$13.2M | |
| 3 | -$8.42M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$7.99M |
| 5 |
AG
Artal Group
Luxembourg
|
-$5.75M |